News
News - Virginia Mines Inc. ("Virginia") (TSX:VGQ) was awarded the "Community Involvement - IBR-QCA Company" during the 6th Annual Stock Company Gala that was held in Quebec City on April 3, 2013. This award recognizes the importance of a public company's involvement in the community. This is the second time Virginia has been recognized, in less than two months, for its social and environmental involvement.
News - Unipex Group has acquired, through its wholly owned Canadian subsidiary, Unipex Solutions Canada inc., all the issued and outstanding shares of Baralex inc. from Manitex Capital inc. Baralex is based in Kirkland, Quebec whose primary business activities relate to the commercialization of Active Pharmaceutical Ingredients (API) sourced globally and sold to key customers in the pharmaceutical industry inCanada and the United States.
News - Creaform, leader in portable 3D measurement solutions and 3D Engineering Services, is proud to introduce the new Health Care Partner 3D Scanner, the only handheld 3D scanner developed specifically for human body scanning.
News - TransCanada Corp.’s bid to funnel Alberta crude oil east to Quebec refineries and potentially to Canada’s busiest oil port opens the door to new markets for oil sands producers beyond those promised by the long-delayed Keystone XL project.
News - Marmon/Keystone Canada is pleased to announce the opening of the company's seventh warehousing facility, conveniently located just 15 miles southwest of downtown Quebec City near Autoroute 20. The metals service center offers stainless and carbon pipe, tube and bar products to customers within a 160 kilometer service radius of Quebec City. Main industries served include transportation, machining, mining, and manufacturers of hydraulic cylinders and food processing equipment. The 24,500 square-foot service center is staffed by three warehouse employees who operate two overhead cranes and provide cutting services up to 18" OD.
News - For over 20 years now, Professor Simard has been working on genetic susceptibility to breast cancer. These latest research findings helped identify 49 new genetic variations involved in the risk of developing this disease, almost tripling the number of variations now known. In the vast majority of breast cancer cases affecting the general population, it is the interaction between these genetic variations and other environmental and lifestyle factors that is involved in the development of the disease.
News - Pure Encapsulations®, a leading manufacturer of research-based, hypo-allergenic nutritional supplements, is pleased to announce new research findings identifying specific pharmacologic actions on their proprietary fruit and vegetable based polyphenol blends. The study is the result of a comprehensive research collaboration with Atrium Innovations and the Institute of Nutrition and Functional Foods (INAF) based at Université Laval, Quebec, Canada.
News - Millions of Canadians will be glad to hear that needle-free INJEX syringes are now available for purchase from Marketing Medical Canada Inc., a Quebec-based Canadian company specializing in the international distribution of innovative health products. INJEX syringes draw on the principles of biomechanics to deliver virtually pain-free injections directly into subcutaneous fatty tissue. INJEX improves patient quality of life by greatly reducing the discomfort and fear that may come with conventional needle injections.
News - This focused partnering event will showcase cutting edge cancer R&D activities in six regions and clusters. Massachusetts, Quebec, Toulouse, Oslo, the UK "Golden triangle" and the Chicago Cancer Cluster have teamed up to present their innovative oncology pipelines to an international audience as a satellite event to BIO 2013. The compact event features company and poster presentations and focused networking opportunities with an international oncology community.
News - The index, part of the Milken Institute's Access to Global Capital Initiative in partnership with Liquidnet, provides a systematic, data-rich framework to shed light on nations' attractiveness to foreign investors, the kind that commit "patient" capital to strategic projects that benefit all parties well into the future. It not only considers economic variables but also examines key business, legal, and regulatory policies that can drive those decisions.
